HIGHLIGHTS
- who: Posted Date June and colleagues from the National Hospital Organization, Kyushu Medical Center University have published the Article: Gut Microbiome Diversity and Speciufffdc Composition During Immunotherapy in Japanese Responders with Non-Small Cell Lung Cancer, in the Journal: (JOURNAL)
- how: The results indicated that ICI responders had more abundant gut microbes compared with ICI non-responders during ICI therapy.
SUMMARY
Although tumorous PD-L1 expression is a potential biomarker of the ICI therapeutic response, there is no widely accepted optimal biomarker to predict the efficacy of ICI, because ICI response . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.